Zydus Life Settles Patent Dispute with Astellas for $120 Million Over Bladder Medication
Indian pharmaceutical firm Zydus Life agrees to a $120 million settlement with Astellas Pharma, resolving patent litigation concerning the bladder drug mirabegron in the U.S. mark…
Zydus Life Sciences, an Indian pharmaceutical company, has reached a $120 million settlement agreement with Astellas Pharma Inc. to resolve ongoing patent litigation related to the bladder drug mirabegron. The settlement ends the dispute over patent rights in the United States, allowing both parties to avoid protracte…
